TLDR:
- EMV Capital has acquired Martlet Capital’s operational business and will manage its c.£23.3 million portfolio.
- EMV Capital plans to launch two new Martlet funds under its management.
Cambridge-based funder Martlet Capital has announced that EMV Capital, a VC investor specializing in high-growth DeepTech and Life Sciences companies, has acquired its operational business and will now serve as the investment manager for Martlet Capital. EMV Capital will manage Martlet Capital’s portfolio of investments across 53 companies in the DeepTech and life sciences sectors. This acquisition provides EMV Capital with an expanded team of venture capital experts and an increase in Funds Under Management.
In addition, EMV Capital plans to leverage the Martlet brand to potentially launch two new funds managed by EMV Capital, including the Martlet Capital Fund II and Martlet Growth Fund. The transaction aims to maximize returns for Martlet Capital shareholders and further enhance Martlet’s position in Cambridge’s tech ecosystem.
Dr Ilian Iliev, MD of EMV Capital, expressed excitement about the deal and the opportunity to deepen the relationship between the two organizations. Robert Marshall, Founder and Chairman of Martlet Capital, emphasized the company’s commitment to supporting founders and driving early-stage revenue growth. Together, they aim to provide a competitive edge to portfolio companies and contribute meaningfully to aspiring founders.
Founded in 2011, Martlet Capital has a track record of investing in IP-rich, DeepTech, and life sciences startups. Over the years, the company has achieved significant exits through trade sales and IPOs, solidifying its presence in the startup ecosystem. With EMV Capital now at the helm, the future looks promising for Martlet Capital and its portfolio of companies.
